FreeTrader
عضو محترف
HWAY
Healthways posted fiscal Q2 (Feb.) earnings of $0.20 per share, a result that was in-line with the Reuters Estimates consensus. Sales increased 32.8% year/year to $100 mln vs. the $96.2 mln consensus. For Q3, the co. expects EPS of $0.20-0.21 vs. the $0.24 consensus. For FY06, HWAY projects EPS of $1.16-1.19. That range is up from the previously guided $1.10-1.14; the consensus estimate is pegged at $1.12. HWAY expects to register FY06 revs of $415-435 mln, which is up from the previously-expected range of $412-432 mln (consensus $420.65 mln). (Note: EPS consensus and actual figures are reported on a GAAP basis).
.................................
Healthways posted fiscal Q2 (Feb.) earnings of $0.20 per share, a result that was in-line with the Reuters Estimates consensus. Sales increased 32.8% year/year to $100 mln vs. the $96.2 mln consensus. For Q3, the co. expects EPS of $0.20-0.21 vs. the $0.24 consensus. For FY06, HWAY projects EPS of $1.16-1.19. That range is up from the previously guided $1.10-1.14; the consensus estimate is pegged at $1.12. HWAY expects to register FY06 revs of $415-435 mln, which is up from the previously-expected range of $412-432 mln (consensus $420.65 mln). (Note: EPS consensus and actual figures are reported on a GAAP basis).
.................................